Biblio

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

O

You B, Mercier F, Assenat E, Langlois-Jacques C, Glehen O, Soulé J, Payen L, Kepenekian V, Dupuy M, Belouin F, et al. The oncogenic and druggable hPG80 (Progastrin) is overexpressed in multiple cancers and detected in the blood of patients. EBioMedicine. 2019;51:102574.

Pichavaram P, Jablonowski CM, Fang J, Fleming AM, Gil HJin, Boghossian AS, Rees MG, Ronan MM, Roth JA, Morton CL, et al. Oncogenic cells of renal embryonic lineage sensitive to the small molecule inhibitor QC6352 display depletion of KDM4 levels and disruption of ribosome biogenesis. Mol Cancer Ther. 2023.

Eagle K, Jiang Y, Shi X, Li M, Obholzer NP, Hu T, Perez MW, Koren JVrabič, Kitano A, Yi JS, et al. An oncogenic enhancer encodes selective selenium dependency in AML. Cell Stem Cell. 2022.

Eagle K, Jiang Y, Shi X, Li M, Obholzer ND, Hu T, Perez MW, Koren JVrabič, Kitano A, Yi JS, et al. An oncogenic enhancer encodes selective selenium dependency in AML. Cell Stem Cell. 2022;29(4):650.

Ou Z-Y, Wang K, Shen W-W, Deng G, Xu Y-Y, Wang L-F, Zai Z-Y, Ling Y-A, Zhang T, Peng X-Q, et al. Oncogenic FLT3 internal tandem duplication activates E2F1 to regulate purine metabolism in acute myeloid leukaemia. Biochem Pharmacol. 2023:115458.

Fischer AD, Veronese-Paniagua DA, Swaminathan S, Kashima H, Rubin DC, Madison BB. The oncogenic function of PLAGL2 is mediated via ASCL2 and IGF2 and a Wnt-independent mechanism in colorectal cancer. Am J Physiol Gastrointest Liver Physiol. 2023.

Rapin N, Porse BT. Oncogenic fusion proteins expressed in immature hematopoietic cells fail to recapitulate the transcriptional changes observed in human AML. Oncogenesis. 2014;3:e106.

Desai R, Huang L, Gonzalez RS, Muthuswamy SK. Oncogenic GNAS uses PKA-dependent and independent mechanisms to induce cell proliferation in human pancreatic ductal and acinar organoids. Mol Cancer Res. 2023.

He F, Melamed J, Tang M-S, Huang C, Wu X-R. Oncogenic HRAS activates epithelial-mesenchyme transition and confers stemness to p53-deficient urothelial cells to drive muscle invasion of basal subtype carcinomas. Cancer Res. 2015.

Zhao R, Hu Z, Zhang X, Huang S, Yu G, Wu Z, Yu W, Lu J, Ruan B. The oncogenic mechanisms of the Janus kinase-signal transducer and activator of transcription pathway in digestive tract tumors. Cell Commun Signal. 2024;22(1):68.

Capik O, Gundogdu B, Tatar A, Sahin A, Chen F, Creighton CJ, Karatas OFaruk. Oncogenic miR-1825 promotes head and neck carcinogenesis via targeting FREM1. J Cell Biochem. 2023.

Shetzer Y, Molchadsky A, Rotter V. Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation. Cold Spring Harb Perspect Med. 2016.

Anon. Oncogenic Mutations Control Stem Cell Polarization in Colorectal Cancer. Cancer Discov. 2023:OF1.

Insco ML, Abraham BJ, Dubbury SJ, Kaltheuner IH, Dust S, Wu C, Chen KY, Liu D, Bellaousov S, Cox AM, et al. Oncogenic mutations impede nuclear RNA surveillance. Science. 2023;380(6642):eabn7625.

Wang T, Li C, Xia C, Dong Y, Yang D, Geng Y, Cai J, Zhang J, Zhang X, Wang J. Oncogenic NRAS hyper-activates multiple pathways in human cord blood stem/progenitor cells and promotes myelomonocytic proliferation in vivo. Am J Transl Res. 2015;7(10):1963-73.

Qin X, Rodriguez FCardoso, Sufi J, Vlckova P, Claus J, Tape CJ. An oncogenic phenoscape of colonic stem cell polarization. Cell. 2023;186(25):5554-5568.e18.

Dellambra E. Oncogenic ras: A double-edged sword for human epidermal stem and transient amplifying cells. Small GTPases. 2016.

An N, Khan S, Imgruet MK, Jueng L, Gurbuxani S, McNerney ME. Oncogenic RAS promotes leukemic transformation of CUX1-deficient cells. Oncogene. 2023.

Sun J, Shen Q, Lu H, Jiang Z, Xu W, Feng L, Li L, Wang X, Cai X, Jin H. Oncogenic Ras suppresses ING4-TDG-Fas axis to promote apoptosis resistance. Oncotarget. 2015.

Choi D, Spinelli C, Montermini L, Rak J. Oncogenic Regulation Of Extracellular Vesicle Proteome And Heterogeneity. Proteomics. 2018:e1800169.

Sun Y, Li W, Li X, Zheng H, Qiu Y, Yang H. Oncogenic role of karyopherin α2 (KPNA2) in human tumors: A pan-cancer analysis. Comput Biol Med. 2021;139:104955.

Lipsey CC, Harbuzariu A, Daley-Brown D, Gonzalez-Perez RR. Oncogenic role of leptin and Notch interleukin-1 leptin crosstalk outcome in cancer. World J Methodol. 2016;6(1):43-55.

Sunaga N, Kaira K, Shimizu K, Tanaka I, Miura Y, Nakazawa S, Ohtaki Y, Kawabata-Iwakawa R, Sato M, Girard L, et al. The oncogenic role of LGR6 overexpression induced by aberrant Wnt/β-catenin signaling in lung cancer. Thorac Cancer. 2023.

Shu W, Liu G, Dai Y, Feng A, Chen Z, Han J, Li X. The oncogenic role of NKAP in the growth and invasion of colon cancer cells. Oncol Rep. 2019.

Luo J, Zou H, Guo Y, Tong T, Chen Y, Xiao Y, Pan Y, Li P. The oncogenic roles and clinical implications of YAP/TAZ in breast cancer. Br J Cancer. 2023.

Pages